v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income $ 127,353 $ 28,290
Adjustments to reconcile net income to net cash (used) provided in operating activities:    
Investment (income) loss (20,811) 4,918
Net realized and unrealized (gain) loss from consolidated funds’ investments (57,482) 53,272
Accretion of original issue and market discount of consolidated funds’ investments, net 60 (19,759)
Income distributions from corporate investments in funds and companies 7,425 91,148
Cash flows due to changes in operating assets and liabilities:    
Net cash (used in) provided by operating activities (212,939) 277,733
Cash flows from investing activities:    
Distributions and proceeds from corporate investments in funds and companies 3,500 2,500
Net cash provided by investing activities 3,500 2,500
Cash flows from financing activities:    
Net cash provided by (used in) financing activities 326,805 (117,359)
Effect of exchange rate changes on cash    
Effect of exchange rate changes on cash (361) 232
Net increase in cash and cash-equivalents 117,005 163,106
Cash and Cash Equivalents    
Cash and cash-equivalents, beginning balance 190,740 449,851
Cash and cash-equivalents, ending balance 307,745 612,957
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents 307,745 612,957
Oaktree    
Cash flows due to changes in operating assets and liabilities:    
Increase in other assets (4,425) (13,176)
Increase in net due from affiliates 0 (776)
Decrease in accrued compensation expense (291) (267)
Increase (decrease) in accounts payable, accrued expenses and other liabilities 558 (155)
Cash flows from financing activities:    
Capital contributions, net 59,716 39,811
Distributions to Class A unitholders (3,900) (167,945)
Distributions to preferred unitholders (6,829) (6,829)
Cash and Cash Equivalents    
Cash and cash-equivalents, ending balance 1,929 15,882
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents 1,929 15,882
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Increase (decrease) in accounts payable, accrued expenses and other liabilities 10,415 7,565
Decrease in dividends and interest receivable 5,612 6,533
Increase in receivables for investments sold (17,903) (68,333)
Decrease in other assets 3,995 4,497
Increase in payables for investments purchased 50,806 15,453
Purchases of investments (808,045) (881,153)
Proceeds from maturities and sales of investments 489,794 1,049,676
Cash flows from financing activities:    
Contributions from non-controlling interests 260,384 286,054
Distributions to non-controlling interests (29,539) (367,821)
Borrowings on credit facilities 345,447 470,730
Repayments on credit facilities (298,474) (371,359)
Cash and Cash Equivalents    
Cash and cash-equivalents, ending balance 305,816 597,075
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents $ 305,816 $ 597,075